Quinolinyl modulators of RORγt
US10201546B2 · kind B2 · utility
0Cited by
27References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2017 |
| Grant date | Feb 12, 2019 |
| Priority date | — |
| Expiry date | Mar 2, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention comprises compounds of Formula I. wherein: The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.